Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer
Claessens, Anouk K. M., Erdkamp, Frans L. G., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M.Journal:
Acta Oncologica
DOI:
10.1080/0284186X.2020.1731923
Date:
March, 2020
File:
PDF, 1.39 MB
2020
File converter
More search results
More benefits 
